Calliditas Therapeutics Pink Sheet Forward View - Accumulation Distribution
| CLTEF Stock | USD 0.59 0.00 0.00% |
Calliditas Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of Calliditas Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 5th of February 2026 the relative strength index (rsi) of Calliditas Therapeutics' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Calliditas Therapeutics hype-based prediction, you can estimate the value of Calliditas Therapeutics AB from the perspective of Calliditas Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Calliditas Therapeutics after-hype prediction price | USD 0.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Calliditas |
Calliditas Therapeutics Additional Predictive Modules
Most predictive techniques to examine Calliditas price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Calliditas using various technical indicators. When you analyze Calliditas charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Calliditas Therapeutics Volatility | Backtest Calliditas Therapeutics | Information Ratio |
Calliditas Therapeutics Trading Date Momentum
| On February 05 2026 Calliditas Therapeutics AB was traded for 0.59 at the closing time. The highest daily price throughout the period was 0.59 and the lowest price was 0.59 . There was no trading activity during the period 0.0. Lack of trading volume on 02/05/2026 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Calliditas Therapeutics to competition
Calliditas Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calliditas Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Calliditas Therapeutics could also be used in its relative valuation, which is a method of valuing Calliditas Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Calliditas Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Calliditas Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Calliditas Therapeutics shares will generate the highest return on investment. By undertsting and applying Calliditas Therapeutics pink sheet market strength indicators, traders can identify Calliditas Therapeutics AB entry and exit signals to maximize returns.
Calliditas Therapeutics Risk Indicators
The analysis of Calliditas Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Calliditas Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting calliditas pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3336.9 | |||
| Standard Deviation | 9810.18 | |||
| Variance | 9.623961921E7 | |||
| Downside Variance | 1217.22 | |||
| Semi Variance | (1,120) | |||
| Expected Short fall | (7,583) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Calliditas Therapeutics
The number of cover stories for Calliditas Therapeutics depends on current market conditions and Calliditas Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Calliditas Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Calliditas Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Calliditas Pink Sheet
Calliditas Therapeutics financial ratios help investors to determine whether Calliditas Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Calliditas with respect to the benefits of owning Calliditas Therapeutics security.